This CTD dossier owner and manufacturer, established in 2010, specializes in the development, manufacturing, and commercialization of generic medications. Headquartered in a state-of-the-art facility in the MENA region, they boast the largest dedicated Cephalosporin plant in the area, highlighting their expertise in this therapy area. They also possess a world-class oral solid dosage form manufacturing facility for Capsules, Tablets, and Dry-Suspension. Their products include various third-generation cephalosporin formulations in different dosages and forms targeting infections. The company is GMP certified by both local and international regulatory bodies, demonstrating their commitment to quality. They have a strong track record of success with a dedicated team of professionals led by an experienced Managing Director.